Pancreas Adenocarcinoma (MSI-H)
4 clinical trials · Condition
◉ Watch Pancreas Adenocarcinoma (MSI-H)
| Record | Firm | Date |
|---|---|---|
| A Beta-only IL-2 ImmunoTherapY Study (NCT05086692) | Medicenna Therapeutics, Inc. | 2021-08-27 |
Track Pancreas Adenocarcinoma (MSI-H) automatically
Every clearance here is in the API, with alerts when new ones post.